Everolimus s1120
Everolimus (S1120) is a chemical compound used as a reference standard and research tool. It is a potent inhibitor of the mammalian target of rapamycin (mTOR) pathway, which is involved in cellular growth and proliferation. Everolimus (S1120) is commonly used in cell-based assays and biochemical studies to investigate the role of the mTOR signaling cascade.
Lab products found in correlation
3 protocols using everolimus s1120
Trastuzumab and PI3K/mTOR Inhibitors
Western Blot Antibody Reagents for Cell Signaling
Human and Mouse Renal Cell Carcinoma Cell Lines
Everolimus (S1120) and ABT-737 (S1002) were purchased from Selleck Chemicals. Stock concentrations were prepared in DMSO and stored according to the manufacturer's protocol.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!